Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Zager

Showing results (151-160 of 247) with videos related to

Pageof 25
Sort By:
Annals of Surgical Oncology|June 12, 2020
Sentinel Lymph Node Biopsy Is Prognostic in Thickest Melanoma Cases and Should Be Performed for Thick MelanomasDale Han, Gang Han, Monica T Duque, et al.
Cancer Control : Journal of the Moffitt Cancer Center|February 10, 2023
Atypical Fibroxanthoma: Outcomes from a Large Single Institution SeriesErin McClure, Michael J Carr, Ayushi Patel, et al.
Annals of Surgical Oncology|August 7, 2021
Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node DissectionKristy K Broman, Deepti Bettampadi, Jaileene Pérez-Morales, et al.
Clinical & Experimental Metastasis|August 16, 2012
Progression of cutaneous melanoma: implications for treatmentStanley P L Leong, Martin C Mihm, George F Murphy, et al.
Cancer Control : Journal of the Moffitt Cancer Center|October 1, 2013
Identifying risk factors using a skin cancer screening programJeremy R Etzkorn, Rajiv P Parikh, Suroosh S Marzban, et al.
Journal of Surgical Oncology|February 9, 2019
Management of intussusception in patients with melanomaMatthew C Perez, James Sun, Clara Farley, et al.
Cancer|February 14, 2015
Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanomaMaki Yamamoto, Kate J Fisher, Joyce Y Wong, et al.
Annals of Surgical Oncology|January 22, 2022
Is There a Relationship Between TILs and Regression in Melanoma?Steven Morrison, Gang Han, Faith Elenwa, et al.
Cancer Epidemiology|March 26, 2013
Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinomaGabriella M Anic, Vernon K Sondak, Jane L Messina, et al.
Cancer|October 13, 2017
Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapiesSarah Sloot, Yian A Chen, Xiuhua Zhao, et al.
Pageof 25

Showing results (151-160 of 247) with videos related to

Sort By:
Pageof 25
Annals of Surgical Oncology|June 12, 2020
Sentinel Lymph Node Biopsy Is Prognostic in Thickest Melanoma Cases and Should Be Performed for Thick MelanomasDale Han, Gang Han, Monica T Duque, et al.
Cancer Control : Journal of the Moffitt Cancer Center|February 10, 2023
Atypical Fibroxanthoma: Outcomes from a Large Single Institution SeriesErin McClure, Michael J Carr, Ayushi Patel, et al.
Annals of Surgical Oncology|August 7, 2021
Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node DissectionKristy K Broman, Deepti Bettampadi, Jaileene Pérez-Morales, et al.
Clinical & Experimental Metastasis|August 16, 2012
Progression of cutaneous melanoma: implications for treatmentStanley P L Leong, Martin C Mihm, George F Murphy, et al.
Cancer Control : Journal of the Moffitt Cancer Center|October 1, 2013
Identifying risk factors using a skin cancer screening programJeremy R Etzkorn, Rajiv P Parikh, Suroosh S Marzban, et al.
Journal of Surgical Oncology|February 9, 2019
Management of intussusception in patients with melanomaMatthew C Perez, James Sun, Clara Farley, et al.
Cancer|February 14, 2015
Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanomaMaki Yamamoto, Kate J Fisher, Joyce Y Wong, et al.
Annals of Surgical Oncology|January 22, 2022
Is There a Relationship Between TILs and Regression in Melanoma?Steven Morrison, Gang Han, Faith Elenwa, et al.
Cancer Epidemiology|March 26, 2013
Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinomaGabriella M Anic, Vernon K Sondak, Jane L Messina, et al.
Cancer|October 13, 2017
Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapiesSarah Sloot, Yian A Chen, Xiuhua Zhao, et al.
Pageof 25